mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.02 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.02 |
mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
-0.43 |
0.02 |
mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
NSC-87877 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.03 |